Changes related to "Pegylated liposomal doxorubicin (Doxil)"
This is a list of changes made recently to pages linked from a specified page (or to members of a specified category). Pages on your watchlist are bold.
22 June 2018
| m 22:32 | Diffuse large B-cell lymphoma (2 changes | history) . . (-927) . . [Jwarner (2×)] | |
| m | 22:32 (cur | prev) . . (+49) . . Jwarner (talk | contribs) (→R-CHOP-14 {{#subobject:fc3bde|Regimen=1}}) | |
| m | 19:16 (cur | prev) . . (-976) . . Jwarner (talk | contribs) (→R-CVP {{#subobject:1b5df7|Regimen=1}}) |
| m 22:24 | Multiple myeloma (diff | hist) . . (+1,337) . . Jwarner (talk | contribs) (→Bortezomib & Dexamethasone {{#subobject:899402|Regimen=1}}) |
| m 15:42 | Ovarian cancer (diff | hist) . . (-60) . . Jwarner (talk | contribs) |
20 June 2018
| 15:05 | Breast cancer (6 changes | history) . . (+3,855) . . [Jwarner (6×)] | |
| m | 15:05 (cur | prev) . . (+17) . . Jwarner (talk | contribs) (→Variant #1, 20 mg/m2 weekly {{#subobject:96cac2|Variant=1}}) | |
| m | 11:01 (cur | prev) . . (-8) . . Jwarner (talk | contribs) (→Paclitaxel monotherapy, q3wk {{#subobject:3e5448|Regimen=1}}) | |
| m | 11:00 (cur | prev) . . (+1,748) . . Jwarner (talk | contribs) (→Gemcitabine & Bevacizumab {{#subobject:134dbe|Regimen=1}}) | |
| 10:56 (cur | prev) . . (+2,990) . . Jwarner (talk | contribs) (→Metastatic disease, maintenance after first-line therapy) | ||
| m | 10:52 (cur | prev) . . (+1,616) . . Jwarner (talk | contribs) (→Gemcitabine monotherapy {{#subobject:b240d6|Regimen=1}}) | |
| m | 10:49 (cur | prev) . . (-2,508) . . Jwarner (talk | contribs) (→GT (Taxol) {{#subobject:1285e|Regimen=1}}) |
| m 14:53 | Diffuse large B-cell lymphoma (3 changes | history) . . (+491) . . [Jwarner (3×)] | |
| m | 14:53 (cur | prev) . . (+213) . . Jwarner (talk | contribs) | |
| m | 13:43 (cur | prev) . . (+2,393) . . Jwarner (talk | contribs) (→R-DHAP {{#subobject:18c266|Regimen=1}}) | |
| m | 13:37 (cur | prev) . . (-2,115) . . Jwarner (talk | contribs) (→ROAD {{#subobject:0d0c67|Regimen=1}}) |
| m 11:42 | Uterine cancer (diff | hist) . . (+30) . . Jwarner (talk | contribs) |
| m 11:11 | Multiple myeloma (diff | hist) . . (+6) . . Jwarner (talk | contribs) |
| m 10:46 | Esophageal cancer (diff | hist) . . (+180) . . Jwarner (talk | contribs) (→FOLFOX-C {{#subobject:e51095|Regimen=1}}) |
19 June 2018
| m 23:01 | Esophageal cancer (diff | hist) . . (-35) . . Jwarner (talk | contribs) |
| m 17:36 | HIV-associated lymphoma (2 changes | history) . . (+195) . . [Jwarner (2×)] | |
| m | 17:36 (cur | prev) . . (+2,688) . . Jwarner (talk | contribs) (→Upfront therapy) | |
| m | 17:35 (cur | prev) . . (-2,493) . . Jwarner (talk | contribs) (→DR-COP {{#subobject:ec091e|Regimen=1}}) |
| m 17:30 | Vascular sarcoma (diff | hist) . . (+20) . . Jwarner (talk | contribs) (→Kaposi sarcoma, all lines of therapy) |
| m 17:29 | Ovarian cancer (diff | hist) . . (+66) . . Jwarner (talk | contribs) (→Relapsed or recurrent disease, platinum-resistant) |
| m 17:24 | Breast cancer (diff | hist) . . (-260) . . Jwarner (talk | contribs) |
| m 11:26 | Multiple myeloma (diff | hist) . . (+1,082) . . Jwarner (talk | contribs) |
18 June 2018
| 23:14 | Esophageal cancer (6 changes | history) . . (+3,152) . . [Jwarner (2×); Nainasingh (4×)] | |
| m | 23:14 (cur | prev) . . (+149) . . Jwarner (talk | contribs) | |
| m | 22:00 (cur | prev) . . (+9) . . Jwarner (talk | contribs) (→Capecitabine, Paclitaxel, RT {{#subobject:17bbec|Regimen=1}}) | |
| 18:41 (cur | prev) . . (+1,269) . . Nainasingh (talk | contribs) (→Regimen ) (Tag: Visual edit) | ||
| 18:09 (cur | prev) . . (+635) . . Nainasingh (talk | contribs) (→Regimen ) (Tag: Visual edit) | ||
| 17:50 (cur | prev) . . (+1,066) . . Nainasingh (talk | contribs) (→Variant #1 ) (Tag: Visual edit) | ||
| 17:10 (cur | prev) . . (+24) . . Nainasingh (talk | contribs) (→Chemotherapy) (Tag: Visual edit) |
| m 20:56 | Hodgkin lymphoma (2 changes | history) . . (+148) . . [Jwarner (2×)] | |
| m | 20:56 (cur | prev) . . (+4) . . Jwarner (talk | contribs) (→Subsequent treatment) | |
| m | 20:55 (cur | prev) . . (+144) . . Jwarner (talk | contribs) (→Consolidation after upfront therapy) |
| m 17:42 | Multiple myeloma (5 changes | history) . . (-83) . . [Jwarner (5×)] | |
| m | 17:42 (cur | prev) . . (-94) . . Jwarner (talk | contribs) | |
| m | 17:41 (cur | prev) . . (+3,384) . . Jwarner (talk | contribs) (→VT {{#subobject:e94510|Regimen=1}}) | |
| m | 17:37 (cur | prev) . . (-3,293) . . Jwarner (talk | contribs) (→Bortezomib & Prednisone {{#subobject:ee2988|Regimen=1}}) | |
| m | 17:13 (cur | prev) . . (+2,087) . . Jwarner (talk | contribs) (→PAD {{#subobject:955a56|Regimen=1}}) | |
| m | 16:58 (cur | prev) . . (-2,167) . . Jwarner (talk | contribs) (→BDD {{#subobject:6ab815|Regimen=1}}) |
17 June 2018
| m 20:33 | Hodgkin lymphoma (2 changes | history) . . (+3,054) . . [Jwarner (2×)] | |
| m | 20:33 (cur | prev) . . (+2,141) . . Jwarner (talk | contribs) (→ABVD {{#subobject:8b9772|Regimen=1}}) | |
| m | 20:19 (cur | prev) . . (+913) . . Jwarner (talk | contribs) (→Escalated BEACOPP {{#subobject:ca99d7|Regimen=1}}) |
| m 16:19 | Breast cancer (5 changes | history) . . (+2,908) . . [Jwarner (5×)] | |
| m | 16:19 (cur | prev) . . (+1,300) . . Jwarner (talk | contribs) (→Docetaxel monotherapy {{#subobject:47db8e|Regimen=1}}) | |
| m | 16:07 (cur | prev) . . (+315) . . Jwarner (talk | contribs) (→Docetaxel monotherapy {{#subobject:45c144|Regimen=1}}) | |
| m | 16:04 (cur | prev) . . (+314) . . Jwarner (talk | contribs) (→Docetaxel monotherapy {{#subobject:1216fd|Regimen=1}}) | |
| m | 16:02 (cur | prev) . . (+691) . . Jwarner (talk | contribs) (→AC {{#subobject:647f67|Regimen=1}}) | |
| m | 15:48 (cur | prev) . . (+288) . . Jwarner (talk | contribs) (→AC {{#subobject:77b0fd|Regimen=1}}) |
